The intersection of patent strategy and FDA regulatory strategy is a critical consideration for medical device companies. A well-integrated approach can create powerful barriers to entry, strengthen intellectual property (IP)...more
7/16/2025
/ FDA Approval ,
FOIA ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Investors ,
Medical Devices ,
Patent Applications ,
Patent Portfolios ,
Patent Term Extensions ,
Patents ,
Product Labels ,
Regulatory Requirements ,
Risk Management